Call: 0123456789 | Email: info@example.com

Category Archives: Immune Systems


Within the quest to develop new, more practical first-line remedies for malignant pleural mesothelioma, it now appears to be like like Ofev (nintedanib) is out of the working. Section III outcomes of the LUME-Meso mesothelioma trial are in and so Read more…


There is new evidence that low doses of the drug Opdivo (nivolumab) may extend lung cancer survival as well as the standard dose—at a much lower cost. The news may have implications for people with the lung-related asbestos cancer, malignant Read more…


Recent research suggests that how people with lung cancers like pleural mesothelioma are treated by their oncology nurses can have a direct bearing on their treatment outcomes. The news is based on a groundbreaking study conducted at two Chinese universities Read more…